Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / EGRX - Eagle Pharmaceuticals EPS misses by $0.49 misses on revenue


EGRX - Eagle Pharmaceuticals EPS misses by $0.49 misses on revenue

Eagle Pharmaceuticals (EGRX): Q1 Non-GAAP EPS of $0.24 misses by $0.49; GAAP EPS of -$0.03 misses by $0.23.Revenue of $41.25M (-10.4% Y/Y) misses by $3.78M.2021 Expense GuidanceR&D spend in 2021, on a non-GAAP basis, is expected to be $26-$30 million, as compared to $27.8 million in 2020.SG&A spend in 2021, on a non-GAAP basis, is expected to be $52-$56 million, as compared to $50.9 million in 2020. This represents a reduction from earlier guidance for 2021 SG&A spend of $56-60 million.Press Release

For further details see:

Eagle Pharmaceuticals EPS misses by $0.49, misses on revenue
Stock Information

Company Name: Eagle Pharmaceuticals Inc.
Stock Symbol: EGRX
Market: NASDAQ
Website: eagleus.com

Menu

EGRX EGRX Quote EGRX Short EGRX News EGRX Articles EGRX Message Board
Get EGRX Alerts

News, Short Squeeze, Breakout and More Instantly...